Traditional herbal management of sickle cell anemia: Lessons from Nigeria

Anemia

Volumn 2012, Issue , 2012, Pages

  Ameh, Sunday J ^a   Tarfa, Florence D ^a   Ebeshi, Benjamin U ^b  

^a NATIONAL INSTITUTE FOR PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (Nigeria)

^b NIGER DELTA UNIVERSITY   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

CHENOPODIUM AMBROSIOIDES; ENTANDROPHRAGMA UTILE; PETIVERIA ALLIACEA;

EID: 84873856895     PISSN: 20901267     EISSN: 20901275     Source Type: Journal    
DOI: 10.1155/2012/607436     Document Type: Review

References (63)

1. Cox F. E. G., History of the discovery of the malaria parasites and their vectors. Parasites & Vectors 2010 3, article 5 10. 1186/1756-3305-3-5
2. Etkin N., Edible Medicines: An Ethnopharmacology of Food 2006 University of Arizona Press
3. Jones G., Dictionary of Mythology Folklore and Symbols 1962 New York, NY, USA The Scarecrow Press
4. Nzewi E., Malevolent ogbanje: recurrent reincarnation or sickle cell disease? Social Science & Medicine 2001 52 9 1403 1416 10. 1016/S0277-9536(00)00245-8 (Pubitemid 32177781)
5. Achebe C., Things Fall Apart 1958 London, UK William Heinemann limited
6. Sickle-cell anaemia-Report by the Secretariat. 2006, http://apps.who.int/ gb/ebwha/pdf-files/WHA59/A59-9-en.pdf
7. Jastaniah W., Epidemiology of sickle cell disease in Saudi Arabia. Annals of Saudi Medicine 2011 31 3 289 293 2-s2.0-79959247655 10.4103/0256-4947.81540
8. Steiner C., Miller J., Sickle cell disease patients in U.S. hospitals, 2004 Healthcare Cost and Utilization Project (HCUP). Statistical Brief No. 21, December 2006. Rockville, Md: Agency for Health-care Research and Quality, http://www.hcup-us.ahrq.gov/reports/statbriefs/sb21.pdf
9. Awasthy N., Aggarwal K. C., Goyal P. C., Prasad M. S., Saluja S., Sharma M., Sickle cell disease: experience of a tertiary care center in a nonendemic area. Annals of Tropical Medicine and Public Health 2008 1 1 1 4 10. 4103/1755-6783. 43069
10. Bardakdjian-Michau J., Bahuau M., Hurtrel D., Godart C., Riou J., Mathis M., Goossens M., Neonatal screening for sickle cell disease in France. Journal of Clinical Pathology 2009 62 1 31 33 2-s2.0-58349095749 10.1136/jcp.2008.058867
11. "Genes and Human Disease. Genomic Resource Centre" Health Topic 2011 Geneva, Switzerland WHO
12. Piel F. B., Patil A. P., Howes R. E., Nyangiri O. A., Gething P. W., Williams T. N., Weatherall D. J., Hay S. I., Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis. Nature Communications 2010 1 8, article 104 2-s2.0-78650101852 10.1038/ncomms1104
13. Allison A. C., The distribution of the sickle-cell trait in East Africa and elsewhere, and its apparent relationship to the incidence of subtertian malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 1954 48 4 312 318 2-s2.0-0001761726
14. Ameh S. J., Obodozie O. O., Inyang U. S., Abubakar M. S., Garba M., Preedy V. R., Watson R. R., Patel V. B., Climbing black pepper (Piper guineense) seeds as an antisickling remedy. Nuts & Seeds in Health and Disease Prevention 2011 1st London, UK Academic Press 333 343
15. Camerino D. C., Tricarico D., Desaphy J. F., Ion channel pharmacology. Neurotherapeutics 2007 4 2 184 198 10. 1016/j.nurt. 2007. 01. 013 (Pubitemid 46467548)
16. Ameh S. J., Obodozie O. O., Babalola P. C., Gamaniel K. S., Medical herbalism and herbal clinical research-a global perspective. British Journal of Pharmaceutical Research 2011 1 4 99 123
17. Ameh S. J., Obodozie O. O., Chindo B. A., Babalola P. C., Gamaniel K. S., Herbal clinical trials-historical development and application in the 21st Century. Pharmacologia 2012 3 121 131 10. 5567/pharmacologia. 2012. 121. 131
18. Swift R., Formulation and standardization of a sickle cell disease drug for clinical trial. SBIR/ STTR of the United States of America. Agency: department of Health and Human Services, Agency Tracking Number:HL099190, Contact: 1R43HL099190-01, Principal Investigator: Robert Swift
19. Fred Senese, General Chemistry Online. Fire and spices. http://antoine.frostburg.edu/chem/senese/101/features/capsaicin.shtml
20. Planells-Cases R., García-Martínez C., Royo M., Pérez-Payá E., Carreño C., Albericio F., Messeguer A., Ferrer-Montiel A., Small molecules targeting the vanilloid receptor complex as drugs for inflammatory pain. Drugs of the Future 2003 28 8 787 795 2-s2.0-0242386586 10.1358/dof.2003.028.08.747395 (Pubitemid 37345317)
21. Iannone R., Ohene-Frempong K., Fuchs E. J., Casella J. F., Chen A. R., Bone marrow transplantation for sickle cell anemia: progress and prospects. Pediatric Blood and Cancer 2005 44 5 436 440 2-s2.0-18144375208 10.1002/pbc.20169 (Pubitemid 40614490)
22. PRICKLY ASH BARK (Zanthoxylum species). An mhtm document by Dr. Tillotson of Tillotson Institute of Natural Health, 2011
23. Modell B., Darlison M., Global Epidemiology of Haemoglobin Disorders and Derived Service Indicators 2008 Geneva, Switzerland WHO Bulletin of the World Health Organization
24. Wambebe C., Khamofu H., Momoh J. A., Ekpeyong M., Audu B. S., Njoku O. S., Bamgboye E. A., Nasipuri R. N., Kunle O. O., Okogun J. I., Enwerem M. N., Audam J. G., Gamaniel K. S., Obodozie O. O., Samuel B., Fojule G., Ogunyale O., Double-blind, placebo-controlled, randomised cross-over clinical trial of NIPRISAN in patients with sickle cell disorder. Phytomedicine 2001 8 4 252 261 2-s2.0-0034887027 (Pubitemid 32758340)
25. Obodozie O. O., Ameh S. J., Afolabi E. K., Standardization of the components of Niprisan: a phytomedicine for treating sickle cell disease. Journal of Medicinal Plants Research 2009 3 4 284 289 2-s2.0-77749283116 10.3109/19390210903534988
26. Nietert P. J., Silverstein M. D., Abboud M. R., Sickle cell anaemia: epidemiology and cost of illness. Pharmacoeconomics 2002 20 6 357 366 2-s2.0-0036296313 (Pubitemid 34712968)
27. Sofowora E. A., Isaacs W. A., Reversal of sickling and crenation in erythrocytes by the root extract of Fagara zanthoxyloides. Lloydia 1971 34 4 383 385 2-s2.0-0015162582
28. Sofowora E. A., Sofowora A., Sodeye A. I., Isolation and characterization of an antisickling agent from the root of Fagara zanthoxyloides. Proceedings of a Symposium Fagara and the Red Blood Cell 1979 Ile-Ife, Nigeria University of Ife Press 79 87
29. Thomas K. D., Ajani B., Antisickling agent in an extract of unripe pawpaw fruit (Carica papaya). Transactions of the Royal Society of Tropical Medicine and Hygiene 1987 81 3 510 511 2-s2.0-0023076665
30. Ogunyemi C. M., Elujoba A. A., Durosimi M. A., Antisickling properties of Carica papaya Linn. Journal of Natural Products 2008 1 56 66
31. Imaga N. O., Gbenle G. O., Okochi V. I., Akanbi S. O., Edeoghon S. O., Oigbochie V., Kehinde M. O., Bamiro S. B., Antisickling property of Carica papaya leaf extract. African Journal of Biochemistry Research 2009 3 4 102 106
32. Ohnishi S. T., Ohnishi T., Ogunmola G. B., Sickle cell anemia: a potential nutritional approach for a molecular disease. Nutrition 2000 16 5 330 338 2-s2.0-0034191994 10.1016/S0899-9007(00)00257-4 (Pubitemid 30227689)
33. Mpiana P. T., Mudogo V., Kabangu Y. F., Tshibangu D. S. T., Ngbolua K. N., Atibu E. K., Mangwala K. P., Mbala M. B., Makelele L. K., Bokota M. T., Antisickling activity and thermostability of anthocyanins extract from a congolese plant, Hymenocardia acida Tul. (Hymenocardiaceae). International Journal of Pharmacology 2009 5 1 65 70 2-s2.0-68949127248 10.3923/ijp.2009.65.70
34. Ekeke G. I., Shode F. O., Phenylalanine is the predominant antisickling agent in Cajanus cajan seed extract. Planta Medica 1990 56 1 41 43 2-s2.0-0025264640 (Pubitemid 20124684)
35. Akinsulie A. O., Temiye E. O., Akanmu A. S., Lesi F. E. A., Whyte C. O., Clinical evaluation of extract of Cajanus cajan (Ciklavit) in sickle cell anaemia. Journal of Tropical Pediatrics 2005 51 4 200 205 2-s2.0-25644442481 10.1093/tropej/fmh097 (Pubitemid 41444436)
36. Fall A. B., Vanhaelen-Fastré R., Vanhaelen M., Lo I., Toppet M., Ferster A., Fondu P., In vitro antisickling activity of a rearranged limonoid isolated from Khaya senegalensis. Planta Medica 1999 65 3 209 212 2-s2.0-0000765957 10.1055/s-1999-14083 (Pubitemid 29186071)
37. Mojisola C. O. C., Anthony E. A., Alani D. M., Antisickling properties of the fermented mixture of Carica papaya Linn and Sorghum bicolor (L.) Moench. African Journal of Pharmacy and Pharmacology 2009 3 4 140 143 2-s2.0-77953661741
38. Awodogan A. A., Wambebe C., Gamaniel K., Okogun J., Orisadipe A., Akah P., Acute and short-term toxicity of NIPRISAN in rats I: biochemical Study. Journal of Pharmaceutical Research & Development 1996 2 39 45
39. Gamaniel K., Amos S., Akah P., Samuel B., Olusola A., Abayomi O., Okogun J., Wambebe C., Pharmacological profile of NIPRD 94/002/1-0: a novel herbal antisickling agent. Journal of Pharmaceutical Research & Development 1998 3 2 89 94
40. Obodozie O. O., Ameh S. J., Afolabi E. K., Oyedele E. O., Ache T. A., Onanuga C. E., Ibe M. C., Inyang U. S., A normative study of the components of niprisan-an herbal medicine for sickle cell anemia. Journal of Dietary Supplements 2010 7 1 21 30 2-s2.0-77749283116 10.3109/19390210903534988
41. Herrick J., Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. Archives of Internal Medicine 1910 6 517 521
42. Pauling L., Itano H. A., Singer S. J., Wells I. C., Sickle cell anemia, a molecular disease. Science 1949 110 2865 543 548 2-s2.0-0000192486
43. Ingram V. M., Gene mutations in human hæmoglobin: the chemical difference between normal and sickle cell hæmoglobin. Nature 1957 180 4581 326 328 2-s2.0-1842337282 10.1038/180326a0
44. Ingram V. M., Abnormal human haemoglobins. III the chemical difference between normal and sickle cell haemoglobins. Biochimica et Biophysica Acta 1959 36 2 402 411 2-s2.0-0001665613
45. Gabriel A., Przybylski J., Sickle-cell anemia: a look at global haplotype distribution. Nature Education 2010 3 3 2 12
46. Okpuzor J., Adebesin O., Ogbunugafor H., Amadi I., The potential of medicinal plants in sickle cell disease control: a review. International Journal of Biomedical and Health Sciences 2008 4 2 47 55
47. Mason V. R., Sickle cell anemia. Journal of the American Medical Association 1922 79 14 1318 1320
48. Sickle Cell Disease: History And Origin. The Internet Journal of Haematology 1 (2), 2011, http://www.ispub.com/ostia/index.php?xmlFilePath= journals/ijhe/vol1n2/sickle.xml
49. From 1918 Autopsy, A First Glimpse of Sickle Cell-and a Warning. http://www.wired.com/wiredscience/2010/11/from-a-1918-autopsy-a-first-glimpse- of-sickle-cell-%E2%80%94%C2%A0and-a-warning
50. Weatherall D. J., Clegg J. B., Inherited haemoglobin disorders: an increasing global health problem. Bulletin of the World Health Organization 2001 79 8 704 712 2-s2.0-0034889014 (Pubitemid 32776838)
51. Ndefo U. A., Maxwell A. E., Nguyen H., Chiobi T. L., Pharmacological management of sickle cell disease. P and T 2008 33 4 238 243 2-s2.0-43149111819 (Pubitemid 351644519)
52. Safo M. K., Abdulmalik O., Danso-Danquah R., Burnett J. C., Nokuri S., Joshi G. S., Musayev F. N., Asakura T., Abraham D. J., Structural basis for the potent antisickling effect of a novel class of five-membered heterocyclic aldehydic compounds. Journal of Medicinal Chemistry 2004 47 19 4665 4676 2-s2.0-4444233550 10.1021/jm0498001 (Pubitemid 39195557)
53. Walder J. A., Zaugg R. H., Iwaoka R. S., Watkin W. G., Klotz I. M., Alternative aspirins as antisickling agents: acetyl-3,5-dibromosalicylic acid. Proceedings of the National Academy of Sciences of the United States of America 1977 74 12 5499 5503 2-s2.0-0017639145
54. Abraham D. J., Mehanna A. S., Wireko F. C., Whitney J., Thomas R. P., Orringer E. P., Vanillin, a potential agent for the treatment of sickle cell anemia. Blood 1991 77 6 1334 1341 2-s2.0-0025855331
55. Nnamani I. N., Joshi G. S., Danso-Danquah R., Abdulmatik O., Asakuru T., Abraham D. J., Safo M. K., Pyridyl derivatives of benzaldehyde as potential antisickling agents. Chemistry and Biodiversity 2008 5 9 1762 1769 2-s2.0-56149107027 10.1002/cbdv.200890165
56. Ion Channels: structure and function. 2011, http://www.whatislife.com/ reader/channels/channels.html
57. Vennekens R., Owsianik G., Nilius B., Vanilloid transient receptor potential cation channels: an overview. Current Pharmaceutical Design 2008 14 1 18 31 2-s2.0-39449132224 10.2174/138161208783330763 (Pubitemid 351266981)
58. Venkatachalam K., Montell C., TRP channels. Annual Review of Biochemistry 2007 76 387 417 10. 1146/annurev.biochem.75.103004.142819
59. Loging W., Harland L., Williams-Jones B., The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. Nature Reviews Drug Discovery 2007 6 5 357 372 2-s2.0-34447531948 10.1038/nrd2337 (Pubitemid 47064566)
60. Caterina M. J., Schumacher M. A., Tominaga M., Rosen T. A., Levine J. D., Julius D., The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997 389 6653 816 824 2-s2.0-0030777012 10.1038/39807 (Pubitemid 27462969)
61. Graham E. S., Ashton J. C., Glass M., Cannabinoid receptors: a brief history and 'what's hot'. Frontiers in Bioscience 2009 14 3 944 957 2-s2.0-63849237026 10.2741/3288
62. Gertsch J., Leonti M., Raduner S., Racz I., Chen J. Z., Xie X. Q., Altmann K. H., Karsak M., Zimmer A., Beta-caryophyllene is a dietary cannabinoid. Proceedings of the National Academy of Sciences of the United States of America 2008 105 26 9099 9104 2-s2.0-48249115990 10.1073/pnas. 0803601105
63. Eya W., Nigeria: Sickle Cell-Lambo Presents Ciklavit at WHO 2006 4th Lagos, Nigeria Daily Champion